BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8224157)

  • 1. Intraorganellar localization of CoASH-independent phytanic acid oxidation in human liver peroxisomes.
    Pahan K; Singh I
    FEBS Lett; 1993 Oct; 333(1-2):154-8. PubMed ID: 8224157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytanic acid oxidation: topographical localization of phytanoyl-CoA ligase and transport of phytanic acid into human peroxisomes.
    Pahan K; Singh I
    J Lipid Res; 1995 May; 36(5):986-97. PubMed ID: 7544821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytanic acid must be activated to phytanoyl-CoA prior to its alpha-oxidation in rat liver peroxisomes.
    Watkins PA; Howard AE; Mihalik SJ
    Biochim Biophys Acta; 1994 Oct; 1214(3):288-94. PubMed ID: 7918611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
    Pahan K; Khan M; Singh I
    J Lipid Res; 1996 May; 37(5):1137-43. PubMed ID: 8725164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytanic acid activation in rat liver peroxisomes is catalyzed by long-chain acyl-CoA synthetase.
    Watkins PA; Howard AE; Gould SJ; Avigan J; Mihalik SJ
    J Lipid Res; 1996 Nov; 37(11):2288-95. PubMed ID: 8978480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytanic acid alpha-oxidation in rat liver peroxisomes. Production of alpha-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors.
    Mihalik SJ; Rainville AM; Watkins PA
    Eur J Biochem; 1995 Sep; 232(2):545-51. PubMed ID: 7556205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes.
    Singh I; Pahan K; Singh AK; Barbosa E
    J Lipid Res; 1993 Oct; 34(10):1755-64. PubMed ID: 7504046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz.
    Singh I; Pahan K; Dhaunsi GS; Lazo O; Ozand P
    J Biol Chem; 1993 May; 268(14):9972-9. PubMed ID: 8486724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisomal beta-oxidation of branched chain fatty acids in rat liver. Evidence that carnitine palmitoyltransferase I prevents transport of branched chain fatty acids into mitochondria.
    Singh H; Beckman K; Poulos A
    J Biol Chem; 1994 Apr; 269(13):9514-20. PubMed ID: 8144536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of phytanic acid and pristanic acid in man: a review.
    Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
    J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of the phytanic acid alpha-oxidation pathway: identification of pristanal as product of the decarboxylation of 2-hydroxyphytanoyl-CoA.
    Verhoeven NM; Schor DS; ten Brink HJ; Wanders RJ; Jakobs C
    Biochem Biophys Res Commun; 1997 Aug; 237(1):33-6. PubMed ID: 9266824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisomes contain a specific phytanoyl-CoA/pristanoyl-CoA thioesterase acting as a novel auxiliary enzyme in alpha- and beta-oxidation of methyl-branched fatty acids in mouse.
    Westin MAK; Hunt MC; Alexson SEH
    J Biol Chem; 2007 Sep; 282(37):26707-26716. PubMed ID: 17613526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome: direct, unequivocal evidence for the new, revised pathway of phytanic acid alpha-oxidation in humans.
    Jansen GA; Mihalik SJ; Watkins PA; Moser HW; Jakobs C; Denis S; Wanders RJ
    Biochem Biophys Res Commun; 1996 Dec; 229(1):205-10. PubMed ID: 8954107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
    Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
    J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-oxidation of 3-methyl-branched fatty acids: a revised pathway confined to peroxisomes.
    Croes K; Van Veldhoven PP; Mannaerts GP; Casteels M
    Lipids; 1999; 34 Suppl():S159. PubMed ID: 10419133
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
    Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
    Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytanic acid alpha-oxidation in rat liver mitochondria.
    Pahan K; Gulati S; Singh I
    Biochim Biophys Acta; 1994 Dec; 1201(3):491-7. PubMed ID: 7803482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human metabolism of phytanic acid and pristanic acid.
    Verhoeven NM; Jakobs C
    Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate specificity of rat liver mitochondrial carnitine palmitoyl transferase I: evidence against alpha-oxidation of phytanic acid in rat liver mitochondria.
    Singh H; Poulos A
    FEBS Lett; 1995 Feb; 359(2-3):179-83. PubMed ID: 7867794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoconazole and other imidazole derivatives are potent inhibitors of peroxisomal phytanic acid alpha-oxidation.
    Pahan K; Khan M; Smith BT; Singh I
    FEBS Lett; 1995 Dec; 377(2):213-6. PubMed ID: 8543053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.